Craniopharyngiomas are epithelial tumors that arise from embryonic epithelial cells of the craniopharyngeal duct. They account for 1.2-4% of all primary intracranial neoplasms and 5-10% of intracranial tumors in children.
Although these tumors are rarely malignant, they often grow adjacent to and distort critical neurovascular structures, particularly the visual pathways and hypothalamus, leading to significant morbidity and mortality. In addition, their sellar or parasellar location poses a challenge to surgical access. However, recent advances in microsurgical and skull base techniques have made resection possible in many patients. 2 
Historical Perspective
Early attempts at resecting skull base tumors, among them cranio- 
Pre-operative Clinical Considerations
In order to assist with surgical resection, craniopharyngiomas have Endocrine dysfunction is common and caused by compression of the hypothalamic-hypophyseal axis by the tumor. Children often present with short stature or diabetes insipidus, and hypothalamic symptoms may be present; adolescents may present with delayed or arrested puberty. Cortisol and thyroid hormones (thyroid-stimulating hormone
[TSH], thyroxine, and triiodothyronine) are the most relevant hormones prior to surgery as deficits may have a profound impact on the peri-operative course; however, growth hormone, insulin-like growth factor-1, serum prolactin, follicule-stimulating hormone, leuteinizing hormone, and testosterone and estradiol in male and female patients, respectively, should be measured to obtain a pre-operative baseline. Stress-dose exogenous glucocorticoids should be administered due to the risk for hypocortisolemia in all patients. Oral thyroid hormone replacement should ideally be started one week prior to surgery in order to achieve a euthyroid state. Intravenous (IV) hormone replacement should be reserved for urgent cases. 
Surgical Evidence
Despite high morbidity, most neurosurgeons have considered gross total resection (GTR) to be the 'cure' for craniopharyngiomas. 12, 13 However, due to this high morbidity some surgeons advocate a subtotal resection (STR) with concomitant radiotherapy as an alternative therapy.
Several studies have found that partial resection and post-operative radiotherapy yield similar disease control rates to GTR with the additional benefit of decreased morbidity. [14] [15] [16] [17] [18] [19] [20] Puget et al. 
Surgical Approaches
The surgical approach is predominantly influenced by the tumor location with respect to the sella, chiasm, and third ventricle. The ideal approach often varies on a case-by-case basis due to the large number of patient-and tumor-dependent variables incorporated into the decision to use a certain approach. Anterior midline, anterolateral, and intraventricular approaches each carry advantages and disadvantages that must be considered in each case (see Table 1 ).
Anterior Midline Approach
Historically, there has been significant debate as to whether the trans-sphenoidal or the subfrontal approach is more appropriate for craniopharyngioma resection. 15 Currently, both approaches are used depending on surgeon preference. The trans-sphenoidal approach is most appropriate for grade I and II (intrasellar and subdiaphragmatic) tumors because it allows access to the sellar and suprasellar regions with a decreased risk for visual injury. Disadvantages include that it may be difficult in young children with a non-pneumatized sphenoid sinus and the approach carries a higher risk for CSF leak. The subfrontal approach is most appropriate for grade III and IV suprasellar tumors. This approach allows for a straight frontal trajectory with direct access to the anterior third ventricle through the lamina terminalis 7 and enables pre-chiasmatic dissection of the tumor.
Case series examining this approach have demonstrated that, regardless of size, at least 90% of all craniopharyngiomas can be removed using the subfrontal and pterional approaches. 1, 6, 10, 13 Potential complications of the subfrontal approach include the risk for potential violation of the frontal sinus as well as damage to the olfactory tract.
In addition, this approach may be technically more complicated in the presence of a pre-fixed chiasm, although this is not an absolute contraindication to the use of the subfrontal approach.
Anterolateral Approach
The pterional approach is often used in craniopharyngioma resection due to its advantages in accessing the suprasellar cistern, facilitating the resection of intrasellar, suprasellar, pre-chiasmatic, and retrochiasmatic tumors. 7, 13 This approach has significant disadvantages; a restricted view of the contralateral opticocarotid triangle, the contralateral retrocarotid space, 11 and the ipsilateral hypothalamic wall makes visualization of the posterior third ventricle across the lamina terminalis especially difficult. 4 The orbitozygomatic approach expands on the pterional approach with the addition of removal of the supraorbital rim, zygomatic arch, or both, thus increasing access to the posterior clinoid, basilar apex, and suprasellar region and improved maneuverability of surgical instruments to these regions. 7, [22] [23] [24] This approach is useful for lesions with significant suprasellar extension.
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Translamina Terminalis
The translamina terminalis approach provides another option to access the third ventricle. It entails opening the lamina terminalis, which is a soft, thin white-matter structure located in the anterior ventricular wall and bound by the optic tracts medially, by the posterior edge of the optic chiasm anteriorly, and by the anterior commissure posteriorly. A pterional or a subfrontal approach can be used to access the lamina terminalis;
however, a pterional approach may be more appropriate as the tumor may force the chiasm toward the tuberculum sellae, effectively making it prefixed and less amenable to a subfrontal approach. 27 
Combined Approaches
In some cases, a combination of the above approaches may be employed.
The subtemporal-transpetrosal approach can be used for primarily retrochiasmatic unilateral tumors that extend to the posterior fossa along the clivus. 26 The pterional-transcallosal approach can aid removal of adherent and calcified tumor within the third ventricle. The transsphenoidal and transcallosal approaches have also been combined with the pterional approach to allow resection of large craniopharyngiomas.
When the transcallosal approach is combined with the pterional approach, intraventricular portions of the tumor should be removed first, with the pterional approach only being performed if basal portions of the tumor remain inaccessible. 7 The subfrontal-pterional approach has been utilized to remove lateral parts of tumor within the Sylvian fissure. 
Radiation Therapy
Several alternative therapies can be considered when GTR is not a possibility. Adjuvant radiotherapy may follow STR and be administered via conventional RT, intracavitary radiation, or fractionated radiotherapy and as stereotactic radiosurgery. 30 Although radiotherapy is generally performed as an adjuvant treatment for craniopharyngiomas, there are examples of it being used as a primary treatment modality. Gopalan et al. 31 performed a meta-analysis of 10 studies to examine the utility, morbidity, and mortality of gamma knife surgery (GKS) in craniopharyngioma treatment. Overall tumor control rates were excellent, with single-type tumors demonstrating better control rates than mixed-type tumors. 32 The mean morbidity rate after GKS was 4%, with a mortality rate of 5% seen in only one study (0.05% overall mortality rate across all studies reviewed). Favorable quality of life outcome was associated with tumors that decreased in size following GKS, while poor outcomes were associated with tumor progression.
GKS involves the delivery of a single high-dose fraction of radiation to a precise target determined by stereotactic neuroimaging-based planning. The precision of targeting and the steep dose fall-off allows for
relative sparing of surrounding structures such as the hypothalamus and the visual pathways. A limitation to the use of radiotherapy for craniopharyngioma is the radio-sensitivity of the adjacent visual pathways, which are generally restricted to a dose of <8Gy. 30 Although the optimal dose has been reported to range from 9 to 12Gy, and thus exceeds the dose limit of the optic pathways, therapeutic effect has been reported with a lower marginal dose of 6Gy. 30, [32] [33] [34] Despite these limitations, GKS can play an important role in reducing recurrence rates when GTR is not feasible.
Stereotactic treatment carries advantages over conventional fractionated radiation therapy by allowing for greater precision and thereby reducing the volume of irradiated brain tissue. 35 In addition, this modality allows delivery of higher radiation doses with less damage to adjacent neurological structures; for example, the tolerance of the optic chiasm to fractionated stereotactic radiotherapy is reported to be 54Gy/30 fractions compared with a reported 8-9Gy tolerance when delivered as a single fraction. 36 Minniti et al. 37 reported a five-year progression-free survival rate of 92% for fractionated stereotactic radiosurgery compared with 80-90%
for complete excision and 50-60% for partial resection. However, despite these encouraging survival rates, vasculitis, neuropsychological changes, increased visual deficits, and secondary tumors can complicate the use of fractionated stereotactic radiotherapy. 
Outcomes
Tumor Recurrence and Survival Literature values for overall survival range from 80 to 91% at five-year follow-up regardless of treatment modality. 43, 44 The best predictor of survival has been shown to be an absence of recurrence. When recurrences do occur, they do so at mean or median intervals ranging from one to 4.3 years. Treatment of recurrences is difficult, and peri-operative mortality is significantly increased compared with treatment of primary tumor. Scarring from the primary surgery or from radiotherapy decreases the rate of total removal and increases the peri-operative mortality. 8, 14 Radiotherapy with or without surgery is an effective treatment modality for recurrent tumor and significantly prevents further tumor progression. Hakuba et al. 26 report a 15-year progression-free survival of 72% after radiotherapy, while Stripp et al. 8 report a 10-year local control rate of 83% after radiotherapy.
Morbidity and Management of Complications
Patients with craniopharyngioma often suffer from endocrine dysfunction and surgical intervention does not seem to reverse existing pre-operative pituitary hormone deficits. The probabilities of GH, folliclestimulating luteinizing hormone (FSH/LH), adrenocorticotropic hormone (ACTH), and TSH deficiencies and diabetes insipidus as 88, 90, 86, 80, and 65, respectively, were reported by Karavitaki et al. 11 Conditions that should be addressed during the pre-operative evaluation include diabetes insipidus, hypoadrenalism, and hypothyroidism, which have all been shown to increase intra-and post-operative morbidity rates. 32 Treatment of long-term hormone deficits varies based on the type of deficiency and is best addressed by an endocrinologist. Despite advances in microsurgical technique, hypopituitarism is extremely common and often requires lifelong treatment.
One of the most common presenting symptoms in patients with craniopharyngioma are visual field defects. Visual fields/visual acuity reportedly improved or stabilized in 74% of patients. 45 However, despite this, the incidence of long-term major visual field defects has been reported to be 48% at 10-year follow-up. 11 Despite a progressive reduction in the intra-operative trauma to the hypothalamus due to advances in microsurgical technique, tumors of the sellar region can still result in hypothalamic dysfunction, which can manifest as appetite changes, apathy, sleep disorders, and memory deficits. 14 Hyperphagia and obesity occurs in 26-52% of post-operative patients. 1 The sequelae of obesity in craniopharyngioma patients are similar to those seen in the general population; one study recently reported that long-term mortality rates in adult patients with
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Conclusions
Conclusive treatment for craniopharyngiomas remains a matter of debate. Although GTR yields lower recurrence rates and longer survival, there is a trade-off between efficacy and morbidity. With 
